What Is SS-31?
The only peptide that concentrates directly at the inner mitochondrial membrane — addressing cellular energy failure at its source.
SS-31 (also known as Elamipretide, MTP-131, or Bendavia) is a synthetic tetrapeptide developed by Hazel Szeto and Peter Schiller at Weill Cornell Medicine. It belongs to the Szeto-Schiller peptide family — a class of compounds specifically engineered to target the inner mitochondrial membrane, where the cell's energy production machinery lives.
What makes SS-31 unique among peptides — and among all longevity compounds — is its extraordinary specificity. It doesn't simply support mitochondrial function broadly. It concentrates at cardiolipin — a phospholipid found almost exclusively in the inner mitochondrial membrane that is essential for the function of the electron transport chain complexes that produce ATP. By stabilizing cardiolipin, SS-31 directly restores the structural integrity of the energy production machinery itself.
SS-31 has progressed further through formal clinical development than almost any other peptide discussed in the longevity space — with Phase 2 and Phase 3 trials completed for heart failure with preserved ejection fraction (HFpEF), Barth syndrome, and mitochondrial myopathy. This clinical development history provides an unusually robust safety and efficacy evidence base.
Most mitochondrial supplements — CoQ10, PQQ, NAD+ precursors — support mitochondrial function from the outside. SS-31 works from the inside — it physically enters the mitochondrial membrane and stabilizes the cardiolipin that holds the electron transport chain complexes in their optimal configuration. This is a fundamentally different and more direct mechanism than any other mitochondrial support compound currently available.
How Does SS-31 Work?
Four mechanisms — all centered on the inner mitochondrial membrane.
Cardiolipin is a unique phospholipid found almost exclusively in the inner mitochondrial membrane. It acts as a structural scaffold for the electron transport chain complexes — holding them in the optimal configuration for ATP production. With age and oxidative stress, cardiolipin becomes oxidized and dysfunctional. SS-31 binds to cardiolipin and protects it from oxidation — directly preserving the structural integrity of the energy production machinery.
By stabilizing cardiolipin, SS-31 improves the efficiency of electron transport chain complexes I, III, and IV — the protein complexes that transfer electrons down the chain to ultimately produce ATP. Dysfunctional ETC complexes produce less ATP and more reactive oxygen species (ROS). SS-31 improves both — more ATP production and less oxidative byproduct.
SS-31's aromatic amino acid residues give it direct antioxidant properties at the site of ROS production — the inner mitochondrial membrane. By scavenging ROS precisely where they're generated, SS-31 prevents the oxidative damage that perpetuates mitochondrial dysfunction. This creates a positive feedback loop: less ROS damage → better cardiolipin integrity → more efficient ETC → less ROS production.
The mitochondrial membrane potential (ΔΨm) — the electrochemical gradient across the inner membrane — is the driving force for ATP synthesis. Dysfunctional mitochondria lose membrane potential, reducing ATP output. SS-31's cardiolipin stabilization and ETC optimization restore membrane potential — directly improving the cell's capacity to produce energy.
How SS-31 Reaches the Mitochondria
A unique charge-based targeting system delivers SS-31 precisely to the inner mitochondrial membrane.
What Is SS-31 Used For?
Wherever mitochondrial dysfunction drives disease or decline — SS-31 addresses the root cause.
- Brain Fog & Cognitive PerformanceThe brain's extraordinary energy demand makes it the first organ to suffer from mitochondrial dysfunction. SS-31's restoration of neuronal ATP production directly addresses the energy deficit underlying brain fog, cognitive slowing, and mental fatigue. The nasal spray delivery format provides particularly rapid CNS effect by bypassing the blood-brain barrier via the olfactory pathway.
- Fatigue & Energy RestorationMitochondrial dysfunction is increasingly recognized as a primary driver of chronic fatigue — including post-viral fatigue, Long COVID, and the age-related energy decline that begins in the 40s. SS-31 addresses this at the cellular energy production level rather than through stimulant mechanisms.
- Heart Failure & Cardiovascular HealthThe primary clinical application — SS-31 (as Elamipretide) has completed Phase 3 trials for heart failure with preserved ejection fraction (HFpEF). Cardiac muscle cells have an extraordinarily high mitochondrial density; SS-31's cardioprotective effects are among its most robustly documented in human clinical data.
- Muscle Function & Physical PerformanceSkeletal muscle mitochondrial dysfunction contributes to age-related muscle weakness and reduced exercise capacity. SS-31 has demonstrated improvements in muscle function and exercise tolerance in both clinical trials and real-world functional medicine use.
- Neuroprotection & Neurodegeneration PreventionMitochondrial dysfunction is increasingly recognized as a central feature of neurodegenerative conditions including Alzheimer's and Parkinson's. SS-31's mitochondrial protection mechanism is directly relevant to neuroprotection — particularly in the context of aging-related neurological decline prevention.
- Anti-Aging & LongevityMitochondrial dysfunction is one of the most consistent hallmarks of biological aging — identified in virtually every tissue type. SS-31's ability to restore mitochondrial function addresses aging at a fundamental cellular level, making it a meaningful anchor compound in any serious longevity protocol.
How to Use SS-31
Two delivery methods — each with distinct use cases and onset profiles.
Use nasal spray when the primary goal is cognitive performance or rapid CNS effect — the olfactory pathway delivers SS-31 directly to brain tissue within 15–30 minutes, bypassing the blood-brain barrier entirely. Use SubQ injection when the primary goal is systemic mitochondrial support — fatigue, cardiac function, muscle performance, or whole-body longevity. For comprehensive coverage, some practitioners use both — nasal for acute cognitive needs, SubQ for ongoing systemic maintenance.
SS-31 in a Mitochondrial Longevity Stack
SS-31 anchors the mitochondrial layer — the cellular energy foundation that all other longevity interventions depend on.
- +SS-31 + NAD+ — The most powerful mitochondrial combination. SS-31 restores the structural integrity of the electron transport chain via cardiolipin stabilization; NAD+ provides the electron carrier substrate that the ETC requires to function. Think of SS-31 as fixing the engine and NAD+ as providing the fuel. Together they address mitochondrial dysfunction from the structural (SS-31) and metabolic (NAD+) angles simultaneously — producing greater ATP restoration than either alone.
- +SS-31 + Semax — The definitive cognitive mitochondrial stack. SS-31 restores neuronal energy production at the mitochondrial level; Semax drives BDNF upregulation and neuroplasticity — the structural changes that better cognition requires. Energy without neuroplasticity produces a powered-up but unchanged brain. Neuroplasticity without energy produces structural potential with no fuel to realize it. Together they address both constraints on cognitive performance simultaneously.
- +SS-31 + Epithalon — Deep sleep is when mitochondrial repair and biogenesis peak — the overnight window when cells rebuild their energy production machinery. Epithalon restores the deep sleep architecture that makes this repair possible; SS-31 directly supports the mitochondrial function being repaired. A natural pairing for anyone experiencing both energy decline and sleep disruption — which is the majority of adults over 45.
- +SS-31 + BPC-157 — BPC-157 reduces systemic inflammation and gut-brain axis dysfunction; SS-31 addresses the mitochondrial energy deficit that inflammation perpetuates. Chronic inflammation is both a cause and consequence of mitochondrial dysfunction — BPC-157 addresses the inflammatory driver while SS-31 repairs the mitochondrial damage it causes. A meaningful combination for any chronic condition with both inflammatory and energy components.
Frequently Asked Questions
CoQ10 supports mitochondrial function from outside the inner membrane — it acts as an electron carrier in the ETC but doesn't address the structural cardiolipin dysfunction that underlies age-related mitochondrial decline. SS-31 enters the inner membrane itself and stabilizes cardiolipin — addressing the root structural cause. Additionally, CoQ10 bioavailability is notoriously poor, especially in older adults. SS-31 concentrates at the target site at 1000x the surrounding cellular concentration — a degree of targeting precision CoQ10 cannot achieve.
Via nasal spray for cognitive applications, many users report noticeable improvement in mental clarity and energy within 30–60 minutes. For systemic SubQ use, meaningful energy and fatigue improvements typically develop over 1–2 weeks of consistent dosing. Clinical trial data shows measurable improvements in cardiac function and exercise capacity within 4–8 weeks of consistent use.
SS-31 (Elamipretide) has been specifically studied in cardiac patients through Phase 2 and Phase 3 trials — making it one of the most extensively safety-evaluated peptides in clinical use. The Phase 3 PROGRESS-HF trial in heart failure patients showed a favorable safety profile. However, any cardiac patient considering SS-31 must discuss it with their cardiologist — cardiac conditions involve complex medication interactions and require physician oversight for any new intervention.
Research in aged animal models has shown that SS-31 can restore mitochondrial function to levels approaching those of younger animals — not just slow decline but meaningfully reverse functional deterioration. The mechanisms support this: cardiolipin oxidation is reversible with SS-31 intervention, and restored membrane potential enables the mitochondria to resume efficient ATP production. Whether this translates to full reversal in humans is still being established — but the mechanistic and animal evidence is genuinely encouraging.
Look for: Certificate of Analysis confirming ≥98% purity by HPLC, correct molecular weight confirmation (638.78 Da), lyophilized powder for injectable, correct pH formulation for nasal spray (pH 4–6), cold-chain shipping. Confirm the supplier can provide batch-specific testing documentation. SS-31 is technically demanding to synthesize correctly — quality variance between suppliers is significant.
This page is for educational purposes only and does not constitute medical advice. SS-31 (Elamipretide) is an investigational compound not approved by the FDA for any indication outside of clinical trials. Cardiac patients must consult their cardiologist before considering SS-31. Always work with a qualified healthcare provider before beginning any peptide protocol. InformedPeptides.com and its authors are not liable for actions taken based on the content of this page.